$
14.210
+0.2(1.428%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
14.285
Open
14.060
VWAP
14.14
Vol
11.93M
Mkt Cap
9.68B
Low
13.830
Amount
168.76M
EV/EBITDA(TTM)
12.90
Total Shares
679.27M
EV
13.47B
EV/OCF(TTM)
16.67
P/S(TTM)
1.45
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
1.73B
+2.58%
0.284
+5.03%
1.69B
-1.18%
0.264
+1.72%
1.67B
-1.66%
0.248
-0.89%
Estimates Revision
The market is revising Upward the revenue expectations for Avantor, Inc. (AVTR) for FY2025, with the revenue forecasts being adjusted by 0.18% over the past three months. During the same period, the stock price has changed by 13.77%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.18%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.72%
In Past 3 Month
Stock Price
Go Up
up Image
+13.77%
In Past 3 Month
16 Analyst Rating
up Image
20.83% Upside
Wall Street analysts forecast AVTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTR is 17.17 USD with a low forecast of 14.00 USD and a high forecast of 30.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
7 Hold
0 Sell
Moderate Buy
up Image
20.83% Upside
Current: 14.210
sliders
Low
14.00
Averages
17.17
High
30.00
Citi
Neutral
maintain
$14
2025-05-22
Reason
Wells Fargo
Brandon Couillard
Buy
Maintains
$25 → $22
2025-04-17
Reason
Barclays
Luke Sergott
Buy
Maintains
$23 → $18
2025-04-10
Reason
Barclays lowered the firm's price target on Avantor to $18 from $23 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for life science tools and diagnostics group. Tools are still defensive, but less so than in the past given the threat of the pharma-specific tariffs potentially causing another round of budget cuts, the analyst tells investors in a research note. Barclays also downgraded the contract research organizations on lower visibility.
Citigroup
Patrick Donnelly
Hold
Maintains
$22 → $18
2025-03-04
Reason
Barclays
Luke Sergott
Buy
Maintains
$26 → $23
2025-02-10
Reason
Barclays lowered the firm's price target on Avantor to $23 from $26 and keeps an Overweight rating on the shares post the Q4 report. The company reported a mixed quarter and guided below estimates, especially on Q1, which gives little confidence that Labs are going to improve throughout the year, the analyst tells investors in a research note.
Wells Fargo
Brandon Couillard
Buy
Maintains
$28 → $25
2025-02-10
Reason

Valuation Metrics

The current forward P/E ratio for Avantor Inc (AVTR.N) is 13.56, compared to its 5-year average forward P/E of 21.16. For a more detailed relative valuation and DCF analysis to assess Avantor Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
21.16
Current PE
13.56
Overvalued PE
25.32
Undervalued PE
17.01

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average EV/EBITDA
15.90
Current EV/EBITDA
11.21
Overvalued EV/EBITDA
18.20
Undervalued EV/EBITDA
13.60

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
2.26
Current PS
1.44
Overvalued PS
2.69
Undervalued PS
1.83

Financials

Annual
Quarterly
FY2025Q1
YoY :
-5.86%
1.58B
Total Revenue
FY2025Q1
YoY :
+0.75%
147.40M
Operating Profit
FY2025Q1
YoY :
+6.79%
64.50M
Net Income after Tax
FY2025Q1
YoY :
0.00%
0.09
EPS - Diluted
FY2025Q1
YoY :
-23.95%
81.30M
Free Cash Flow
FY2025Q1
YoY :
-0.41%
33.82
Gross Profit Margin - %
FY2025Q1
YoY :
+7.09%
9.97
FCF Margin - %
FY2025Q1
YoY :
+13.33%
4.08
Net Margin - %
FY2025Q1
YoY :
+100.45%
8.98
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
182.6K
USD
4
6-9
Months
0.0
USD
0
0-12
Months
88.3K
USD
1
Bought
0-3
3
928.0K
USD
Months
3-6
4
578.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
512.8K
Volume
2
6-9
Months
3.8M
Volume
4
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
1.0M
Volume
Months
6-9
4
1.6M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
8.0K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

AVTR News & Events

Events Timeline

2025-07-21 (ET)
2025-07-21
07:06:39
Avantor says Emmanuel Ligner to succeed Michael Stubblefield as CEO
select
2025-06-25 (ET)
2025-06-25
15:11:26
NIH directs staff not to end any extra research projects for now, NY Times says
select
link
2025-05-14 (ET)
2025-05-14
09:49:13
Avantor among 'big callouts' from prime broker filings, says Gordon Haskett
select
Sign Up For More Events

News

5.0
07-21NASDAQ.COM
Avantor Appoints Emmanuel Ligner As New President And CEO
5.0
07-21SeekingAlpha
Avantor appoints Emmanuel Ligner president and CEO
5.0
07-21PRnewswire
Avantor Announces Emmanuel Ligner as Next President and CEO
Sign Up For More News

FAQ

arrow icon

What is Avantor Inc (AVTR) stock price today?

The current price of AVTR is 14.21 USD — it has increased 1.43 % in the last trading day.

arrow icon

What is Avantor Inc (AVTR)'s business?

arrow icon

What is the price predicton of AVTR Stock?

arrow icon

What is Avantor Inc (AVTR)'s revenue for the last quarter?

arrow icon

What is Avantor Inc (AVTR)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Avantor Inc (AVTR)'s fundamentals?

arrow icon

How many employees does Avantor Inc (AVTR). have?

arrow icon

What is Avantor Inc (AVTR) market cap?